Cytarabine and daunorubicin (7 plus 3) regimen for remission induction of acute myelogenous leukemia

James Waddell, Dominic A. Solimando

Research output: Contribution to journalReview article

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)1044-1048
Number of pages5
JournalHospital Pharmacy
Volume37
Issue number10
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Daunorubicin
Cytarabine

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Cytarabine and daunorubicin (7 plus 3) regimen for remission induction of acute myelogenous leukemia. / Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 37, No. 10, 01.01.2002, p. 1044-1048.

Research output: Contribution to journalReview article

@article{22d12a1a156a4c76914f58fd2be79339,
title = "Cytarabine and daunorubicin (7 plus 3) regimen for remission induction of acute myelogenous leukemia",
author = "James Waddell and Solimando, {Dominic A.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1177/001857870203701002",
language = "English (US)",
volume = "37",
pages = "1044--1048",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "10",

}

TY - JOUR

T1 - Cytarabine and daunorubicin (7 plus 3) regimen for remission induction of acute myelogenous leukemia

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2002/1/1

Y1 - 2002/1/1

UR - http://www.scopus.com/inward/record.url?scp=0036801470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036801470&partnerID=8YFLogxK

U2 - 10.1177/001857870203701002

DO - 10.1177/001857870203701002

M3 - Review article

VL - 37

SP - 1044

EP - 1048

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 10

ER -